Obermatt
See Similar Stocks →

Joint

NAQ:JYNT · US47973J1025
Health Care Providers & ServicesSmall

360

70
EV / EBIT59
Price / Owner Earnings10
Owner Earnings Yield51
Dividend Yield1
Price/Sales21
EV / Gross Profit96
Price/Book19
Return on Capital23
Cash Return on Capital98
Return on Equity44
EBIT Margin5
Gross Profitability100
Cash Conversion14
Accruals98
Owner Earnings Margin55
Sales growth59
Profit growth18
Reinvestment96
Price momentum14
Debt load91
Refinancing37
Debt Payback100
Liquidity100
Analyst ratings21
Opinion Changes50
Price Target Upside25
Market mood34
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Joint generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryHealth Care Providers & Services
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2010
Employees1,772
Websitethejoint.com
ISINUS47973J1025
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Pain ManagementAlternative MedicineWellness and RecoveryFitnessHealth CarePersonal HealthWellness

Description

The Joint Corp. operates as a growing franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The company will continue the franchise-focused expansion of chiropractic clinics in key markets througho…

Analysis

Middle-of-the-road

The Joint Corp. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 35.4×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is sturdy. The company scores 14/20 on our value-creation score: strong value creator.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
19
2023202420252026

All-time high

82

Jan 2023

All-time low

5

Jan 2024

Average rank

29

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
21
71
79
37
Price/Earnings
58
12
3
5
Price/Book
19
1
10
3
Dividend Yield
1
1
1
1
Value (overall)
20
5
10
4

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Joint with its peers
Lumexa Imaging
NSQ:LMRI
24
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Oncology Institute
NAQ:TOI
52
CountryUSA
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
CVS Health
NYQ:CVS
29
CountryUSA
IndustryHealth Care Providers & Services
SizeXX-Large
Full Stock Analysis →
Community Health Systems
NYQ:CYH
23
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Chemed
NYQ:CHE
75
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
U.S. Physical Therapy
NYQ:USPH
61
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →